Trial intelligence / Profile preview

Tiotropium Bromide in Early-Stage COPD (Isfahan University, 2018–2019)

IRCT20190524043684N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Isfahan University of Medical Sciences. Started Oct 2019; status: completed.

02

Drugs

tiotropium
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on IRCT20190524043684N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190524043684N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call